Axcentria Pharmaceuticals, LLC agreed to acquire all the assets of FIN Branding Group, LLC from Electronic Cigarettes International Group, Ltd. (OTCPK:ECIG.Q) for $0.41 million on June 8, 2017. Under the terms, Axcentria Pharmaceuticals will pay $0.03 million at closing, 50% of the inventory value upon consumption for a period of 6 months which is projected at $0.2 million and 6% of net sales for a period of two years estimated at $0.18 million paid monthly upon completion. On June 8, 2017, the deal was approved from the bankruptcy court. Axcentria Pharmaceuticals, LLC cancelled the acquisition of FIN Branding Group, LLC from Electronic Cigarettes International Group, Ltd. (OTCPK:ECIG.Q) on June 8, 2018.